GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Thera Solutions Ltd (SHSE:688177) » Definitions » EV-to-FCF

Bio-Thera Solutions (SHSE:688177) EV-to-FCF : -15.36 (As of Jun. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Bio-Thera Solutions EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bio-Thera Solutions's Enterprise Value is ¥9,103.3 Mil. Bio-Thera Solutions's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-592.7 Mil. Therefore, Bio-Thera Solutions's EV-to-FCF for today is -15.36.

The historical rank and industry rank for Bio-Thera Solutions's EV-to-FCF or its related term are showing as below:

SHSE:688177' s EV-to-FCF Range Over the Past 10 Years
Min: -68.4   Med: -17.85   Max: 57.8
Current: -15.96

During the past 8 years, the highest EV-to-FCF of Bio-Thera Solutions was 57.80. The lowest was -68.40. And the median was -17.85.

SHSE:688177's EV-to-FCF is ranked worse than
100% of 397 companies
in the Biotechnology industry
Industry Median: 6.4 vs SHSE:688177: -15.96

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-25), Bio-Thera Solutions's stock price is ¥21.17. Bio-Thera Solutions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.900. Therefore, Bio-Thera Solutions's PE Ratio for today is At Loss.


Bio-Thera Solutions EV-to-FCF Historical Data

The historical data trend for Bio-Thera Solutions's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Thera Solutions EV-to-FCF Chart

Bio-Thera Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - -19.52 58.58 -12.26 -23.60

Bio-Thera Solutions Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.77 -13.05 -16.35 -23.60 -25.23

Competitive Comparison of Bio-Thera Solutions's EV-to-FCF

For the Biotechnology subindustry, Bio-Thera Solutions's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Thera Solutions's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Thera Solutions's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Bio-Thera Solutions's EV-to-FCF falls into.



Bio-Thera Solutions EV-to-FCF Calculation

Bio-Thera Solutions's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=9103.346/-592.745
=-15.36

Bio-Thera Solutions's current Enterprise Value is ¥9,103.3 Mil.
Bio-Thera Solutions's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-592.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio-Thera Solutions  (SHSE:688177) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bio-Thera Solutions's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=21.17/-0.900
=At Loss

Bio-Thera Solutions's share price for today is ¥21.17.
Bio-Thera Solutions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.900.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Bio-Thera Solutions EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Bio-Thera Solutions's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Thera Solutions (SHSE:688177) Business Description

Traded in Other Exchanges
N/A
Address
5th Floor, Building A6, 11 Kaiyuan Avenue, Guangzhou High-tech Industrial Development Zone, Science City, Guangdong Province, Guangzhou, CHN, 510530
Bio-Thera Solutions Ltd is engaged in research, development, and production of drugs and biosimilars. The company provides drug research and development; biotechnology consulting and communication services; services; medical research and experimental development; biological drug manufacturing; and pharmaceuticals retail.

Bio-Thera Solutions (SHSE:688177) Headlines

No Headlines